Immune recovery after autologous or rhG-CSF primed PBSC transplantation
Open Access
- 1 May 1996
- journal article
- Published by Wiley in European Journal of Haematology
- Vol. 56 (5), 301-307
- https://doi.org/10.1111/j.1600-0609.1996.tb00719.x
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Do autologous peripheral blood cell transplants provide more than hematopoietic recovery?The International Journal of Cell Cloning, 1995
- A comparative study of the phenotype and proliferative capacity of peripheral blood (PB) CD34+ cells mobilized by four different protocols and those of steady-phase PB and bone marrow CD34+ cellsBlood, 1994
- Syngeneic transplantation with peripheral blood mononuclear cells collected after the administration of recombinant human granulocyte colony-stimulating factorBlood, 1993
- Malignant tγ/δ lymphoproliferative disease with natural killer lytic activityAmerican Journal of Hematology, 1992
- Effect of peripheral-blood progenitor cells mobilised by filgrastim (G-CSF) on platelet recovery after high-dose chemotherapyThe Lancet, 1992
- Functional and phenotypic properties of ‘naive’ and ‘memory’ CD4+ T cells in the humanImmunologic Research, 1991
- Cytolytic activity of human natural killer cell subpopulations isolated by four‐color immunofluorescence flow cytometric cell sortingCytometry, 1990
- GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR TO HARVEST CIRCULATING HAEMOPOIETIC STEM CELLS FOR AUTOTRANSPLANTATIONThe Lancet, 1989
- Endogenously generated activated killer cells circulate after autologous and allogeneic marrow transplantation but not after chemotherapyBlood, 1989
- Human naive and memory T cells: reinterpretation of helper-inducer and suppressor-inducer subsetsImmunology Today, 1988